Skip to main content
TEVA $42.62 +0.12%
TEVA logo
TEVA · Teva Pharmaceutical Industries Ltd
Track TEVA — free
$42.62 +0.05 (+0.12%) At close · Nov 17 Play latest call Q3 2026 earnings call transcript
Market Cap
$49.73B
Shares
1.17B
Volume · Nov 17 7.02M Avg daily vol (3M) 6.16M
All webcasts

Earnings call · FY2020 Q4

Teva Pharmaceutical Industries Ltd (TEVA) Q4 2020 Earnings Call

Concluded Feb 10, 2021
Feb 10, 2021
Period
FY2020 Q4
Runtime
—
Sources
2 artifacts
Revenue $4.45B -0.3% YoY
Diluted EPS $0.14 +40% YoY
Gross margin 46.0% +2.2 pp YoY
Net income $150.00M +36.4% YoY
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document